ラパマイシン (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "ラパマイシン" in Japanese language version.

refsWebsite

Global rank Japanese rank

9nih.gov

4^th place

24^th place

8doi.org

2^nd place

6^th place

3nikkei.com

211^th place

13^th place

1medscape.com

719^th place

3,311^th place

1fda.gov

447^th place

1,043^rd place

1worldcat.org

5^th place

19^th place

1lww.com

2,769^th place

4,586^th place

1aacrjournals.org

8,869^th place

low place

1web.archive.org

1^st place

1kobe-np.co.jp

2,514^th place

158^th place

1uky.edu

3,273^rd place

5,647^th place

aacrjournals.org

cancerres.aacrjournals.org

Sun SY, Rosenberg LM, Wang X, et al. (August 2005). “Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition”. Cancer Res. 65 (16): 7052–8. doi:10.1158/0008-5472.CAN-05-0917. PMID 16103051 2009年7月8日閲覧。.

doi.org

Simamora, P; Alvarez, JM; Yalkowsky, SH (1 February 2001). “Solubilization of rapamycin”. International journal of pharmaceutics 213 (1–2): 25–9. doi:10.1016/s0378-5173(00)00617-7. PMID 11165091.
“Rapamycin (AY-22,989), a new antifungal antibiotic”. J. Antibiot. 28 (10): 721–6. (October 1975). doi:10.7164/antibiotics.28.721. PMID 1102508.
Seto, Belinda (2012). “Rapamycin and mTOR: a serendipitous discovery and implications for breast cancer”. Clinical and Translational Medicine 1 (1): 29. doi:10.1186/2001-1326-1-29.
Pritchard DI (2005). “Sourcing a chemical succession for cyclosporin from parasites and human pathogens”. Drug Discovery Today 10 (10): 688–691. doi:10.1016/S1359-6446(05)03395-7. PMID 15896681.
Mukherjee, Sandeep; Mukherjee, Urmila (2009-01-01). “A Comprehensive Review of Immunosuppression Used for Liver Transplantation”. Journal of Transplantation 2009: 1–20. doi:10.1155/2009/701464. ISSN 2090-0007. PMC 2809333. PMID 20130772.
“A clinical pharmacokinetic study of tacrolimus and sirolimus combination immunosuppression comparing simultaneous to separated administration.”. Ther Drug Monit. 24 (3): 346–50. (June 2002). doi:10.1097/00007691-200206000-00004. PMID 12021624.
Sun SY, Rosenberg LM, Wang X, et al. (August 2005). “Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition”. Cancer Res. 65 (16): 7052–8. doi:10.1158/0008-5472.CAN-05-0917. PMID 16103051 2009年7月8日閲覧。.
富取秀行、未来のアンチエイジング薬となるか？　加齢現象を遅らせるラパマイシンファルマシア 2013年 49巻 1号 p.68, doi:10.14894/faruawpsj.49.1_68

fda.gov

accessdata.fda.gov

“Rapamune Prescribing Information”. United States Food and Drug Administration. Wyeth Pharmaceuticals, Inc. (May 2015). 28 May 2016閲覧。

kobe-np.co.jp

“iPS創薬の治験開始骨の難病、明石のYさんに世界初”. 神戸新聞. (2017年10月5日) 2017年10月5日閲覧。

lww.com

journals.lww.com

“A clinical pharmacokinetic study of tacrolimus and sirolimus combination immunosuppression comparing simultaneous to separated administration.”. Ther Drug Monit. 24 (3): 346–50. (June 2002). doi:10.1097/00007691-200206000-00004. PMID 12021624.

medscape.com

Buck, Marcia L. (2006). “Immunosuppression With Sirolimus After Solid Organ Transplantation in Children”. Pediatric Pharmacotherapy 12 (2).

nih.gov

pubmed.ncbi.nlm.nih.gov

Simamora, P; Alvarez, JM; Yalkowsky, SH (1 February 2001). “Solubilization of rapamycin”. International journal of pharmaceutics 213 (1–2): 25–9. doi:10.1016/s0378-5173(00)00617-7. PMID 11165091.
“Rapamycin (AY-22,989), a new antifungal antibiotic”. J. Antibiot. 28 (10): 721–6. (October 1975). doi:10.7164/antibiotics.28.721. PMID 1102508.
Pritchard DI (2005). “Sourcing a chemical succession for cyclosporin from parasites and human pathogens”. Drug Discovery Today 10 (10): 688–691. doi:10.1016/S1359-6446(05)03395-7. PMID 15896681.
Mukherjee, Sandeep; Mukherjee, Urmila (2009-01-01). “A Comprehensive Review of Immunosuppression Used for Liver Transplantation”. Journal of Transplantation 2009: 1–20. doi:10.1155/2009/701464. ISSN 2090-0007. PMC 2809333. PMID 20130772.
“A clinical pharmacokinetic study of tacrolimus and sirolimus combination immunosuppression comparing simultaneous to separated administration.”. Ther Drug Monit. 24 (3): 346–50. (June 2002). doi:10.1097/00007691-200206000-00004. PMID 12021624.
Sun SY, Rosenberg LM, Wang X, et al. (August 2005). “Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition”. Cancer Res. 65 (16): 7052–8. doi:10.1158/0008-5472.CAN-05-0917. PMID 16103051 2009年7月8日閲覧。.

pubchem.ncbi.nlm.nih.gov

“Rapamycin”. PubChem Compound. National Center for Biotechnology Information. 1 August 2016閲覧。

ncbi.nlm.nih.gov

Mukherjee, Sandeep; Mukherjee, Urmila (2009-01-01). “A Comprehensive Review of Immunosuppression Used for Liver Transplantation”. Journal of Transplantation 2009: 1–20. doi:10.1155/2009/701464. ISSN 2090-0007. PMC 2809333. PMID 20130772.

pmc.ncbi.nlm.nih.gov

Mukherjee, Sandeep; Mukherjee, Urmila (2009-01-01). “A Comprehensive Review of Immunosuppression Used for Liver Transplantation”. Journal of Transplantation 2009: 1–20. doi:10.1155/2009/701464. ISSN 2090-0007. PMC 2809333. PMID 20130772.

nikkei.com

uky.edu

elegans.uky.edu

「Rapamycin fed late in life extends lifespan in genetically heterogeneous mice」ネイチャー460号 392-395ページ (2009年7月16日)

web.archive.org

“iPS使い創薬、初の治験へ＝骨の難病患者に－9月以降、4大学病院で・京大”. 時事通信社. (2017年8月1日) 2017年8月1日閲覧。

worldcat.org

search.worldcat.org

Mukherjee, Sandeep; Mukherjee, Urmila (2009-01-01). “A Comprehensive Review of Immunosuppression Used for Liver Transplantation”. Journal of Transplantation 2009: 1–20. doi:10.1155/2009/701464. ISSN 2090-0007. PMC 2809333. PMID 20130772.